CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 18, 2023--Enveric Biosciences (NASDAQ: ENVB) (鈥淓nveric鈥� or the 鈥淐ompany鈥�), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, ...
PHILADELPHIA--(BUSINESS WIRE)--Oct 18, 2023--<a ...
OXFORD, England--(BUSINESS WIRE)--Oct 18, 2023--Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch庐 3D genomics platform and Bupa, the UK鈥檚 leading health insurer, announce a strategic agreement to give Bupa ...
TORONTO--(BUSINESS WIRE)--Oct 18, 2023--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation therapies targeting pain and inflammation, is pleased to announce the initiation of the ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct 18, 2023--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from the primary analysis of the Phase III ALINA study demonstrating a statistically significant and clinically meaningful improvement in ...
DUBLIN--(BUSINESS WIRE)--Oct 17, 2023--The <a ...